
TherapeuticsMD, Inc. (TXMD) traded sharply higher today after completing a conference on Wednesday. The company presented at the 37th Annual J.P. Morgan Healthcare Conference, and it is clear that its presentation has had a bullish impact as the stock traded on higher than average volume. However, I think the stock will pull back from here, and I’m therefore targeting a potential entry. Here’s a recap.